Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes

Table 4

Influence of the CAP value on composite outcomes (any morbidity or mortality).

			Any morbidity or mortality		Total
			No	Yes
CAP value (dB/M)	≤248	N	67	33	100
		%	67.0%	33.0%	100.0%
	249–268	N	21	8	29
		%	72.4%	27.6%	100.0%
	269–280	N	15	7	22
		%	68.2%	31.8%	100.0%
	>280	N	242	58	300
		%	80.7%	19.3%	100.0%
Total		N	345	106	451
		%	76.5%	23.5%	100.0%

X² = 9.03; df = 3; . CAP, controlled attenuation parameter.